Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The Promoter SNP, but not the Alternative Splicing SNP, is Linked to Multiple Sclerosis Among Jordanian Patients.
Level of mobility limitations and falls status in persons with multiple sclerosis.
TLR2 and TLR4 in Autoimmune Diseases: a Comprehensive Review.
Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton.
[Every fifth case of multiple sclerosis is familial.]
Bilirubin-induced neural impairment: A special focus on myelination, age-related windows of susceptibility and associated co-morbidities.
Expanding spectrum of neurologic manifestations in patients with NLRP3 low-penetrance mutations.
Multiple sclerosis: Grey matter atrophy in the thoracic spinal cord is associated with disability in patients with multiple sclerosis.
Epidemiological characteristics and functional disability of multiple sclerosis patients in kosovo.
Proteomics of a conundrum: thoughts on addressing the aetiology vs. progression of Multiple Sclerosis.
Environmental factors related to multiple sclerosis in Indian population.
Patient expression of emotions and neurologist responses in first multiple sclerosis consultations.
Supernumerary phantom limbs in ICU patients with acute inflammatory demyelinating polyneuropathy.
Oligodendrogenesis in the fornix of adult mouse brain; the effect of LPS-induced inflammatory stimulation.
Mutation Update of ARSA and PSAP genes causing Metachromatic Leukodystrophy.
Cinnabarinic acid, an endogenous agonist of type-4 metabotropic glutamate receptor, suppresses experimental autoimmune encephalomyelitis in mice.
ZSTK474, a novel PI3K inhibitor, modulates human CD14(+) monocyte-derived dendritic cell functions and suppresses experimental autoimmune encephalomyelitis.
Quantitative MRI and ultrastructural examination of the cuprizone mouse model of demyelination.
Multiple sclerosis: Etiology, incidence and prevalence.
Your client has multiple sclerosis: understanding the challenge.
Timed 25-Foot Walk: Direct evidence that improving 20% or greater is clinically meaningful in MS.
Clinical efficacy of plasmapheresis in patients with neuromyelitis optica spectrum disorder and effects on circulating anti-aquaporin-4 antibody levels.
The cooling effect on proinflammatory cytokines interferon-gamma, tumor necrosis factor-alpha, and nitric oxide in patients with multiple sclerosis.
Clinical application of multi-contrast 7-T MR imaging in multiple sclerosis: increased lesion detection compared to 3 T confined to grey matter.
[Vaccines and central nervous system demyelinating diseases: New studies on the internet –not just new rumors].

Pages